CREATE Medicines, Inc. (formerly Myeloid Therapeutics), a clinical-stage biotech pioneering in vivo multi-immune programming, today announced that clinical results from its Phase 1 MYE Symphony trial ...

The Java virtual machine provides a high-performance, universal runtime for a wealth of popular languages beyond just Java. In this article, we’ll look at the characteristic strengths and common use ...

Data from the Phase 1 CARLYSLE study in severe refractory systemic lupus erythematosus (srSLE) suggests obe-cel is well tolerated with no ICANS ...

Data I/O Corporation expands its Unified Programming Platform Strategy. The Unified Programming Platform supports a transition from design and NPI to automated production. With Data I/O’s refreshed ...

The ongoing global Phase 2b REZOLVE-AD study (NCT06136741) enrolled 393 patients with moderate-to-severe atopic dermatitis who had not previously received treatment with biologic or JAK inhibitor ...

Leading healthcare data abstraction company evolves brand to better represent comprehensive clinical registry expertise across all medical specialties. While we built our reputation on exceptional ...

Hey! I suggest abstracting the user data storage code. The current system could remain as a default option, and plugins could create their own load/save implementation (to avoid adding an extra thing ...

BioStat.AI is built on the foundation of EDETEK's flagship platforms, CONFORM™ and eClinical, and leverages advanced AI technologies including large language models (LLMs), machine learning, and ...